Evidence map›Paper›PMID 37942289›Full record

ArticleFrontiers in molecular biosciences2023

Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies.

Aijun Sun, Fengze Cai, Qingping Xiong, Tong Xie, Xiang Li, Yanteng Xie, Ruiyang Luo, Wenwen Hu, Fei Zhong, Shiyan Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Aijun Sun *Department of Thyroid and Breast Oncological Surgery, The Affiliated Huaian Hospital of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an, Jiangsu, China.
Fengze Cai *School of Life Science and Food Engineering, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Qingping Xiong *Jiangsu Key Laboratory of Regional Resource Exploitation and Medicinal Research, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Tong XieSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Xiang LiSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Yanteng XieSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Ruiyang LuoJiangsu Key Laboratory of Regional Resource Exploitation and Medicinal Research, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Wenwen HuThird Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Fei ZhongDepartment of Laboratory Medicine, The Affiliated Huaian Hospital of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an, Jiangsu, China.
Shiyan WangSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huai'an, Jiangsu, China.
Huaiyin Institute of Technology · CNXuzhou Medical College · CNHenan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ABI3immunotherapypan-cancerprognostic biomarkertumor immunity

Identifiers

PMID37942289
PMCPMC10628744
OpenAlexW4388263582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.